Biosimilar Rituximab Appears to Be Safe in Mixed Cryoglobulinemic Vasculitis – The Center for Biosimilars

Biosimilar Rituximab Appears to Be Safe in Mixed Cryoglobulinemic Vasculitis – The Center for Biosimilars

Biosimilar Rituximab Appears to Be Safe in Mixed Cryoglobulinemic Vasculitis – The Center for Biosimilars
Published on 2019-07-27